FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574122907> ?p ?o ?g. }

• W2574122907 abstract "Topical corticosteroids are the most frequently prescribed dermatological treatment and are often used by pregnant women with skin conditions. However, little is known about their safety in pregnancy.To assess the effects of topical corticosteroids on pregnancy outcomes in pregnant women.This is an update of a review previously published in 2009. We updated our searches of the following databases to July 2015: the Cochrane Skin Group Specialised Register, the Cochrane Pregnancy and Childbirth Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (2015, Issue 6), MEDLINE, EMBASE, and LILACS. We also searched five trials registers and checked the reference lists of included studies, published reviews, articles that had cited the included studies, and one author's literature collection, for further references to relevant RCTs.Randomised controlled trials and cohort studies of topical corticosteroids in pregnant women, as well as case-control studies comparing maternal exposure to topical corticosteroids between cases and controls when studies reported pre-specified outcomes. The primary outcomes included mode of delivery, major congenital abnormality, birth weight, and preterm delivery (delivery before 37 completed weeks gestation); the secondary outcomes included foetal death, minor congenital abnormality, and low Apgar score (less than seven at 5 min).We used standard methodological procedures expected by Cochrane. Two authors independently applied selection criteria, extracted data, and assessed the quality of the included studies. A third author was available for resolving differences of opinion. A further author independently extracted data from included studies that were conducted by authors of this systematic review.We included 7 new observational studies in this update, bringing the total number to 14, including 5 cohort and 9 case-control studies, with 1,601,515 study subjects.Most studies found no causal associations between maternal exposure to topical corticosteroids of any potency and pregnancy outcomes when compared with no exposure. These outcomes included: mode of delivery (risk ratio (RR) 1.04, 95% confidence interval (CI) 0.95 to 1.15, 1 cohort study, n = 9904, low quality evidence); congenital abnormalities, including orofacial cleft or cleft palate and hypospadias (where the urethral opening is on the underside of the penis) (RR 0.82, 95% CI 0.34 to 1.96, 2 cohort studies, n = 9512, low quality evidence; and odds ratio (OR) 1.07, 95% CI 0.71 to 1.60, 1 case-control study, n = 56,557); low birth weight (RR 1.08, 95% CI 0.86 to 1.36; n = 59,419, 4 cohort studies; very low quality evidence); preterm delivery (RR 0.93, 95% CI 0.81 to 1.08, 4 cohort studies, n = 59,419, low quality evidence); foetal death (RR 1.02, 95% CI 0.60 to 1.73, 4 cohort studies, n = 63,885, very low quality evidence); and low Apgar score (RR 0.84, 95% CI 0.54 to 1.31, 1 cohort study, n = 9220, low quality evidence).We conducted stratified analyses of mild or moderate potency, and potent or very potent topical corticosteroids, but we found no causal associations between maternal exposure to topical corticosteroid of any potency and congenital abnormality, orofacial clefts, preterm delivery, or low Apgar score. For low birth weight, although the meta-analysis based on study-level data was not significant for either mild to moderate corticosteroids (pooled RR 0.90, 95% CI 0.74 to 1.09, 3 cohort studies, n > 55,713) or potent to very potent corticosteroids (pooled RR 1.58, 95% CI 0.96 to 2.58, 4 cohort studies, n > 47,651), there were significant differences between the two subgroups (P = 0.04). The results from three of the individual studies in the meta-analysis indicated an increased risk of low birth weight in women who received potent to very potent topical corticosteroids. Maternal use of mild to moderate potency topical steroids was associated with a decreased risk of foetal death (pooled RR 0.70, 95% CI 0.64 to 0.77, 2 studies, n = 48,749; low quality evidence), but we did not observe this effect when potent to very potent topical corticosteroids were given during pregnancy (pooled RR 1.14, 95% CI 0.69 to 1.88, 3 studies, n = 37,086, low quality evidence).We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) Working Group approach to rate the overall quality of the evidence. Data from observational studies started at low quality. We further downgraded the evidence because of imprecision in low birth weight and inconsistency in foetal death. Lower quality evidence resulted in lower confidence in the estimate of effect for those outcomes.This update adds more evidence showing no causal associations between maternal exposure to topical corticosteroids of all potencies and pregnancy outcomes including mode of delivery, congenital abnormalities, preterm delivery, foetal death, and low Apgar score, which is consistent with the previous version of this review. This update provides stratified analyses based on steroid potency; we found no association between maternal use of topical corticosteroids of any potency and an increase in adverse pregnancy outcomes, including mode of delivery, congenital abnormality, preterm delivery, foetal death, and low Apgar score. Similar to the previous version of the review, this update identified a probable association between low birth weight and maternal use of potent to very potent topical corticosteroids, especially when the cumulative dosage of topical corticosteroids throughout the pregnancy is very large, which warrants further investigation. The finding of a possible protective effect of mild to moderate topical corticosteroids on foetal death could also be examined." @default.
• W2574122907 created "2017-01-26" @default.
• W2574122907 creator A5009926815 @default.
• W2574122907 creator A5011497620 @default.
• W2574122907 creator A5042520008 @default.
• W2574122907 creator A5049764403 @default.
• W2574122907 creator A5069720631 @default.
• W2574122907 creator A5082447463 @default.
• W2574122907 date "2015-10-26" @default.
• W2574122907 modified "2023-10-09" @default.
• W2574122907 title "Safety of topical corticosteroids in pregnancy" @default.
• W2574122907 cites W1549963993 @default.
• W2574122907 cites W1575954327 @default.
• W2574122907 cites W1977814077 @default.
• W2574122907 cites W1979035153 @default.
• W2574122907 cites W1982736551 @default.
• W2574122907 cites W1986775958 @default.
• W2574122907 cites W1987081299 @default.
• W2574122907 cites W1991143002 @default.
• W2574122907 cites W1991340804 @default.
• W2574122907 cites W1992518368 @default.
• W2574122907 cites W2001303743 @default.
• W2574122907 cites W2002273520 @default.
• W2574122907 cites W2002897620 @default.
• W2574122907 cites W2022995396 @default.
• W2574122907 cites W2023665902 @default.
• W2574122907 cites W2025595850 @default.
• W2574122907 cites W2026798970 @default.
• W2574122907 cites W2027985523 @default.
• W2574122907 cites W2033750580 @default.
• W2574122907 cites W2035285899 @default.
• W2574122907 cites W2037133034 @default.
• W2574122907 cites W2041134324 @default.
• W2574122907 cites W2047672705 @default.
• W2574122907 cites W2048046716 @default.
• W2574122907 cites W2050599382 @default.
• W2574122907 cites W2060604544 @default.
• W2574122907 cites W2066704280 @default.
• W2574122907 cites W2068943233 @default.
• W2574122907 cites W2080204674 @default.
• W2574122907 cites W2087641300 @default.
• W2574122907 cites W2088329560 @default.
• W2574122907 cites W2090948954 @default.
• W2574122907 cites W2091297917 @default.
• W2574122907 cites W2104457723 @default.
• W2574122907 cites W2104675861 @default.
• W2574122907 cites W2114971155 @default.
• W2574122907 cites W2115201737 @default.
• W2574122907 cites W2122612334 @default.
• W2574122907 cites W2123724816 @default.
• W2574122907 cites W2127441651 @default.
• W2574122907 cites W2135532813 @default.
• W2574122907 cites W2139074554 @default.
• W2574122907 cites W2142654351 @default.
• W2574122907 cites W2151811889 @default.
• W2574122907 cites W2156066470 @default.
• W2574122907 cites W2168852120 @default.
• W2574122907 cites W2178777713 @default.
• W2574122907 cites W2312865146 @default.
• W2574122907 cites W2318894128 @default.
• W2574122907 cites W3150985908 @default.
• W2574122907 cites W4205472387 @default.
• W2574122907 cites W4240295291 @default.
• W2574122907 cites W4244354657 @default.
• W2574122907 cites W4254477044 @default.
• W2574122907 cites W65651801 @default.
• W2574122907 doi "https://doi.org/10.1002/14651858.cd007346.pub3" @default.
• W2574122907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8558096" @default.
• W2574122907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26497573" @default.
• W2574122907 hasPublicationYear "2015" @default.
• W2574122907 type Work @default.
• W2574122907 sameAs 2574122907 @default.
• W2574122907 citedByCount "57" @default.
• W2574122907 countsByYear W25741229072012 @default.
• W2574122907 countsByYear W25741229072013 @default.
• W2574122907 countsByYear W25741229072015 @default.
• W2574122907 countsByYear W25741229072016 @default.
• W2574122907 countsByYear W25741229072017 @default.
• W2574122907 countsByYear W25741229072018 @default.
• W2574122907 countsByYear W25741229072019 @default.
• W2574122907 countsByYear W25741229072020 @default.
• W2574122907 countsByYear W25741229072021 @default.
• W2574122907 countsByYear W25741229072022 @default.
• W2574122907 countsByYear W25741229072023 @default.
• W2574122907 crossrefType "journal-article" @default.
• W2574122907 hasAuthorship W2574122907A5009926815 @default.
• W2574122907 hasAuthorship W2574122907A5011497620 @default.
• W2574122907 hasAuthorship W2574122907A5042520008 @default.
• W2574122907 hasAuthorship W2574122907A5049764403 @default.
• W2574122907 hasAuthorship W2574122907A5069720631 @default.
• W2574122907 hasAuthorship W2574122907A5082447463 @default.
• W2574122907 hasBestOaLocation W25741229072 @default.
• W2574122907 hasConcept C131872663 @default.
• W2574122907 hasConcept C141071460 @default.
• W2574122907 hasConcept C168563851 @default.
• W2574122907 hasConcept C17744445 @default.
• W2574122907 hasConcept C187212893 @default.
• W2574122907 hasConcept C189708586 @default.
• W2574122907 hasConcept C199539241 @default.
• W2574122907 hasConcept C2778052368 @default.

• next